Pfizer Inc Stock Probability Of Bankruptcy
| PFIZ34 Stock | BRL 37.84 0.92 2.37% |
Pfizer |
Pfizer Inc Company chance of distress Analysis
Pfizer's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Pfizer Probability Of Bankruptcy | Less than 10% |
Most of Pfizer's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pfizer Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Pfizer probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Pfizer odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Pfizer Inc financial health.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
| Competition |
Based on the latest financial disclosure, Pfizer Inc has a Probability Of Bankruptcy of 10.0%. This is 76.9% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The probability of bankruptcy for all Brazil stocks is 74.89% higher than that of the company.
Pfizer Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pfizer's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pfizer could also be used in its relative valuation, which is a method of valuing Pfizer by comparing valuation metrics of similar companies.Pfizer is currently under evaluation in probability of bankruptcy category among its peers.
Pfizer Fundamentals
| Return On Equity | 0.37 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.31 % | |||
| Operating Margin | 0.39 % | |||
| Current Valuation | 1.62 T | |||
| Shares Outstanding | 22.45 B | |||
| Price To Earning | 25.90 X | |||
| Price To Book | 3.30 X | |||
| Price To Sales | 15.43 X | |||
| Revenue | 100.33 B | |||
| Gross Profit | 66.11 B | |||
| EBITDA | 39.58 B | |||
| Net Income | 31.37 B | |||
| Cash And Equivalents | 23.9 B | |||
| Cash Per Share | 1.07 X | |||
| Total Debt | 36.2 B | |||
| Debt To Equity | 0.44 % | |||
| Current Ratio | 1.40 X | |||
| Book Value Per Share | 4.13 X | |||
| Cash Flow From Operations | 32.58 B | |||
| Earnings Per Share | 7.24 X | |||
| Price To Earnings To Growth | 1.17 X | |||
| Number Of Employees | 38 | |||
| Beta | 0.58 | |||
| Market Capitalization | 1.3 T | |||
| Total Asset | 181.48 B | |||
| Z Score | 21.0 | |||
| Annual Yield | 0.04 % | |||
| Five Year Return | 3.45 % | |||
| Net Asset | 181.48 B | |||
| Last Dividend Paid | 1.6 |
About Pfizer Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pfizer Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pfizer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pfizer Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Pfizer Stock
When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.